Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Armata Pharmaceuticals, Inc. logo — PURPOSEFUL. PRECISE. POWERFUL.

Armata Pharmaceuticals, Inc.

PURPOSEFUL. PRECISE. POWERFUL.

Founded 2019 United States Los Angeles, United States 71 employees Post Ipo Debt Total: $286.00M Biotechnology, Health Care +1

General Information

Company Name Armata Pharmaceuticals, Inc.
Founded Year 2019
Location United States Los Angeles, United States +3
Founders / Decision Makers
Team member
Employees 71
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Post Ipo Debt
Social

Get notified when Armata Pharmaceuticals, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc. is a biotechnology company founded in 2005, with a focus on developing precisely targeted bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections. The company prides itself on its proprietary bacteriophage-based technology, which underpins a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. With headquarters in the United States, Armata is committed to advancing phage with drug development expertise that spans bench to clinic, and it features in-house phage-specific cGMP manufacturing. The company recently secured a significant $35.00M Post-IPO Debt investment on 04 March 2024, with Innoviva contributing to this funding round. Armata's dedication to combating antibiotic resistance and its strong financial backing position it as an innovative player in the biotechnology and healthcare industry. For more information, visit www.armatapharma.com.

Taxonomy: Therapeutics, Drug Development, Infectious Disease, Microbiome, Targeted Antimicrobials, Bacteriophage, Synthetic Biology, Engineered Phage, Clinical-Stage

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt •••••• 1
Investor
04 Mar 2024
Post-IPO Debt •••••• 1
Investor
11 Jul 2023
Post-IPO Debt •••••• 1
Investor
10 Jan 2023
Post-IPO Equity •••••• 1
Investor
09 Feb 2022
Post-IPO Equity •••••• 2
Investor Investor
28 Oct 2021

View All 10 Funding Rounds

Armata Pharmaceuticals, Inc. Alternatives & Competitors

Armata Pharmaceuticals, Inc. vs
Adaptive Phage Therapeutics
Adaptive Phage Therapeutics United States

To save lives or restore health as a leader in safe, rapidly deployable, cost-effective cures for ba...

Acquired
28 employees
Biotechnology, Health Care
Compare Armata Pharmaceuticals, Inc. vs Adaptive Phage Therapeutics
Armata Pharmaceuticals, Inc. vs
Rime Bioinformatics
Rime Bioinformatics France

Making high performance bioinformatics accessible.

Non Equity Assistance
5 employees
Biotechnology, Clean Energy
Compare Armata Pharmaceuticals, Inc. vs Rime Bioinformatics
Armata Pharmaceuticals, Inc. vs
Locus Biosciences, Inc.
Locus Biosciences, Inc. United States

Locus Biosciences, Inc. is a biotechnology company that develops precision, engineered bacteriophage...

61 employees
Also compare with: Armata Pharmaceuticals, Inc. vs AnBogen Therapeutics AnBogen Therapeutics

FAQ About Armata Pharmaceuticals, Inc.

PURPOSEFUL. PRECISE. POWERFUL.
Armata Pharmaceuticals, Inc. was founded in 2019.
Armata Pharmaceuticals, Inc. is headquartered in Los Angeles, United States.
Armata Pharmaceuticals, Inc. operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Armata Pharmaceuticals, Inc. has approximately 71 employees.
Armata Pharmaceuticals, Inc. has completed 10 funding rounds, raising a total of $286.00M. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to Armata Pharmaceuticals, Inc. include Adaptive Phage Therapeutics, Rime Bioinformatics, Locus Biosciences, Inc., AnBogen Therapeutics, No-Antibiotics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Armata Pharmaceuticals, Inc. and Adaptive Phage Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Armata Pharmaceuticals, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes